Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Ruëff

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Dermatologie (Heidelberg, Germany)|January 12, 2024
[Insect venom allergies-What will change in times of global change?]Franziska Ruëff
Current Opinion in Allergy and Clinical Immunology|August 3, 2020
Natural history and long-term follow-up of Hymenoptera allergyFranziska Ruëff
Current Opinion in Allergy and Clinical Immunology|July 9, 2004
Venom immunotherapy: adverse reactions and treatment failureFranziska Ruëff, Bernhard Przybilla
Deutsches Arzteblatt International|April 26, 2012
Insect stings: clinical features and managementBernhard Przybilla, Franziska Ruëff
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 16, 2009
Hymenoptera venom allergyBernhard Przybilla, Franziska Ruëff
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|November 13, 2003
[Insect venom allergies]Bernhard Przybilla, Franziska Ruëff
MMW Fortschritte Der Medizin|February 2, 2008
[Work-related diseases of the skin]Franziska Ruëff, Bernhard Przybilla
Current Opinion in Allergy and Clinical Immunology|March 4, 2011
Management of occupational Hymenoptera allergyFranziska Ruëff, Rene Chatelain, Bernhard Przybilla
Current Opinion in Allergy and Clinical Immunology|July 11, 2006
Mastocytosis and Hymenoptera venom allergyFranziska Ruëff, Marianne Placzek, Bernhard Przybilla
Allergologie Select|March 18, 2021
Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosisAskin Gülsen, Franziska Ruëff, Uta Jappe
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Dermatologie (Heidelberg, Germany)|January 12, 2024
[Insect venom allergies-What will change in times of global change?]Franziska Ruëff
Current Opinion in Allergy and Clinical Immunology|August 3, 2020
Natural history and long-term follow-up of Hymenoptera allergyFranziska Ruëff
Current Opinion in Allergy and Clinical Immunology|July 9, 2004
Venom immunotherapy: adverse reactions and treatment failureFranziska Ruëff, Bernhard Przybilla
Deutsches Arzteblatt International|April 26, 2012
Insect stings: clinical features and managementBernhard Przybilla, Franziska Ruëff
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 16, 2009
Hymenoptera venom allergyBernhard Przybilla, Franziska Ruëff
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|November 13, 2003
[Insect venom allergies]Bernhard Przybilla, Franziska Ruëff
MMW Fortschritte Der Medizin|February 2, 2008
[Work-related diseases of the skin]Franziska Ruëff, Bernhard Przybilla
Current Opinion in Allergy and Clinical Immunology|March 4, 2011
Management of occupational Hymenoptera allergyFranziska Ruëff, Rene Chatelain, Bernhard Przybilla
Current Opinion in Allergy and Clinical Immunology|July 11, 2006
Mastocytosis and Hymenoptera venom allergyFranziska Ruëff, Marianne Placzek, Bernhard Przybilla
Allergologie Select|March 18, 2021
Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosisAskin Gülsen, Franziska Ruëff, Uta Jappe
Pageof 7